Quality control
Quality control (QC) is the laboratory testing of a finished product batch to verify its identity, purity, and safety before release. It is a final inspection step that uses scientific testing methods to detect defects.
Also called: QC
Quality control (QC) is reactive, laboratory-based testing on a specific manufactured batch after production. It checks identity, chemical purity, and handling safety, then records the results in a Certificate of Analysis (COA), the formal lab report provided with a product. For unregulated research chemicals, understanding QC helps you read lab reports and verify vial contents, because a purity percentage alone is incomplete.
Essential questions answered by a complete quality control review
- Identity by Mass Spectrometry: Is the compound what the label claims? Mass Spectrometry confirms the molecular structure matches the declared substance.
- Purity by High-Performance Liquid Chromatography (HPLC): How chemically clean is it? HPLC separates and quantifies components in the sample.
- Quantity by net content or mass balance: How much actual substance is present in the vial?
- Safety from dangerous contaminants: Is it free of harmful residues such as heavy metals or endotoxins?
Critical distinctions and common pitfalls in quality control
Quality control is often confused with Quality Assurance (QA). QA is a proactive system meant to prevent defects, while QC is reactive testing of the finished batch to detect them. Only QC produces the batch-specific evidence found in a lab report.
A high purity percentage does not prove the correct molecule is in the vial. Complete QC needs both purity and identity evidence, because a sample can be 99% pure and still be the wrong compound. When evaluating lab reports, look for ISO 17025 laboratory accreditation and batch-specific chromatograms that link the results to the exact batch received.
Sources
- [PDF] Guidance for Industry- Synthetic Peptides - FDA
- Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control - PMC
- FDA Sets Peptide Impurity Thresholds as Low as 0.10%, Oath Research Analysis Finds
- Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- [PDF] Analytical Procedures and Methods Validation for Drugs and Biologics
- Slide 1
- Long story short: an introduction to the short-term and longterm Six Sigma quality and its importance in laboratory medicine for the management of extra-analytical processes
- Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
- Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
- Suitability of Short- and Long-Term Storage of Volatile Organic Compounds Samples in Syringe-Based Containers: A Comparison Study
- Quality-Control Analytical Methods: Common Concerns about Out-of-Specification Results
- Peptide Testing: HPLC & Mass Spec Purity Guide | Apex
- Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- Peptide Certificate of Analysis COA Guide for Researchers | Peptide Guides
- Guideline on the Development and Manufacture of Synthetic Peptides
- HPLC vs Mass Spectrometry for Peptide Purity Testing: An Analytical Methods Guide
- How to Read a Peptide COA (Real vs Fake)
- What is quality assurance vs. quality control? 5 key differences